Ye Liu
Chief Executive Officer chez OCUMENSION THERAPEUTICS
Fortune : 22 M $ au 31/03/2024
Profil
Ye Liu is currently the Chief Executive Officer & Executive Director at Ocumension Therapeutics and also serves as a Director at EyePoint Pharmaceuticals, Inc. Prior to his current roles, he served as Chairman & General Manager at Santen Pharmaceutical (China) Co. Ltd., General Manager at Eisai China, Inc., and Head-Sales at Sandoz (China) Pharmaceutical Co., Ltd.
Mr. Liu received his graduate degree from Dalhousie University in 2003 and his undergraduate degree from Zhongshan Hospital Fudan University in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUMENSION THERAPEUTICS
4,37% | 10/01/2024 | 30 384 480 ( 4,37% ) | 22 M $ | 31/03/2024 |
Postes actifs de Ye Liu
| Sociétés | Poste | Début |
|---|---|---|
| OCUMENSION THERAPEUTICS | Chief Executive Officer | 01/08/2018 |
| EYEPOINT PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2021 |
Anciens postes connus de Ye Liu
| Sociétés | Poste | Fin |
|---|---|---|
| Santen Pharmaceutical (China) Co. Ltd. | Chief Executive Officer | 01/07/2018 |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Chief Executive Officer | 01/09/2014 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Sales & Marketing | 01/02/2009 |
Formation de Ye Liu
| Dalhousie University | Graduate Degree |
| Zhongshan Hospital Fudan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| OCUMENSION THERAPEUTICS | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Santen Pharmaceutical (China) Co. Ltd. | |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Health Technology |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz (China) Pharmaceutical Co., Ltd. is a global leader in generic pharmaceuticals and biosimilars. The private company is based in Shanghai, China. Sandoz is dedicated to helping patients increase drug accessibility and providing high-quality, affordable healthcare services to more patients worldwide. Founded in 2007, the Chinese company's purpose is to explore new methods of improving and extending people's lives. | Health Technology |
